Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:antibiotic |
| gptkbp:activeIngredient |
gptkb:linezolid
|
| gptkbp:approvalYear |
2000
|
| gptkbp:approvedBy |
gptkb:United_States
|
| gptkbp:ATCCode |
J01XX08
|
| gptkbp:CASNumber |
165800-03-3
|
| gptkbp:chemicalFormula |
C16H20FN3O4
|
| gptkbp:contraindication |
gptkb:monoamine_oxidase_inhibitors
uncontrolled hypertension |
| gptkbp:drugClass |
oxazolidinone antibiotic
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zyvox
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
protein synthesis inhibitor
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
diarrhea headache thrombocytopenia |
| gptkbp:usedFor |
gptkb:pneumonia
skin infections bacterial infections vancomycin-resistant Enterococcus faecium infections |
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|